Recent Finacing
Recent Raise
Cardior Pharmaceuticals is a clinical-stage Hanover, Germany biopharma developing non-coding RNA therapeutics for heart disease, including CDR132L, an anti‑miR‑132 oligonucleotide advancing from Phase 1b toward Phase 2.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Cardior Pharmaceuticals.
